Abstract

Asthma is a chronic inflammatory disease of the airways, which is characterized by episodes of wheezing, shortness of breath, chest tightness, and coughing, with reversible airway obstruction and airway hyperresponsiveness. Worldwide asthma affects 5-10% of all schoolchildren and in most countries the prevalence is still increasing. Antiinflammatory drugs, with inhaled corticosteroids (ICS) as first choice, are the mainstay of asthma treatment and guidelines recommend a step up-step down scheme when adjusting asthma treatment. The goals of asthma treatment are to reduce symptoms, to allow for a normal and active life, and to reduce future risks to the patient. In this respect ‘asthma control’ has become a central concept in asthma management.

, , , ,
J.C. de Jongste (Johan)
Erasmus University Rotterdam
The BATMAN study was financially supported by Lung Foundation Netherlands, the Netherlands Organisation for Health Research and Development (ZonMW), and Fund Nuts Ohra. Publication of this thesis was financially supported by Stichting Astma Bestrijding, Boehringer Ingelheim, Chiesi pharmaceuticals BV, Chipsoft BV, Glaxosmithkline, Novartis pharma BV, Abbvie BV, and Teva pharma.
hdl.handle.net/1765/77204
Erasmus MC: University Medical Center Rotterdam

Voorend-van Bergen, S. (2014, November 26). Monitoring of Childhood Asthma. Retrieved from http://hdl.handle.net/1765/77204